NYSE · MMSI
Healthcare · Medical - Instruments & Supplies
$85.37
Down-$0.20 (-0.23%)
Updated Sep 20, 2026, 11:40 AM
SID Score
4.3/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
MMSI closed at $85.37 after 19 trading sessions, down 5.44% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $85.03 | $87.33 | $84.12 | $85.37 | 910.44K |
| Sep 17, 2026 | $86.40 | $86.4974 | $85.23 | $85.57 | 319.37K |
| Sep 16, 2026 | $85.49 | $87.68 | $85.31 | $86.14 | 540.64K |
| Sep 15, 2026 | $86.81 | $86.81 | $85.655 | $86.18 | 533.15K |
| Sep 14, 2026 | $87.525 | $87.825 | $86.03 | $87.02 | 385.72K |
| Sep 11, 2026 | $87.49 | $88.195 | $85.40 | $86.36 | 443.19K |
| Sep 10, 2026 | $86.63 | $87.485 | $85.19 | $86.47 | 549.95K |
| Sep 9, 2026 | $86.92 | $87.64 | $86.42 | $87.19 | 475.57K |
| Sep 8, 2026 | $88.47 | $88.91 | $86.715 | $87.38 | 1.42M |
| Sep 4, 2026 | $87.68 | $89.69 | $87.035 | $89.60 | 599.64K |
| Sep 3, 2026 | $90.81 | $91.63 | $88.41 | $88.57 | 606.41K |
| Sep 2, 2026 | $90.42 | $92.18 | $90.065 | $90.13 | 908.78K |
| Sep 1, 2026 | $90.92 | $91.38 | $90.17 | $90.68 | 679K |
| Aug 31, 2026 | $90.13 | $91.3399 | $90.13 | $90.66 | 407.59K |
| Aug 28, 2026 | $89.96 | $90.72 | $89.275 | $90.49 | 341.63K |
| Aug 27, 2026 | $89.58 | $90.26 | $88.58 | $89.54 | 597.61K |
| Aug 26, 2026 | $91.07 | $91.07 | $88.95 | $90.54 | 544.31K |
| Aug 25, 2026 | $90.14 | $91.90 | $90.14 | $91.09 | 711.67K |
| Aug 24, 2026 | $91.00 | $91.51 | $90.0481 | $90.28 | 669.64K |
The latest Smart Investors Daily articles mentioning MMSI.
MMSI research
Company profile and research snapshot.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | B of A Securities | Neutral | — |
| Aug 11, 2026 | BTIG | Buy | — |
| Aug 3, 2026 | Canaccord Genuity | Buy | — |
| Jul 31, 2026 | Piper Sandler | Overweight | — |
| Jul 31, 2026 | JP Morgan | Overweight | — |
No generated briefing is available yet.
Benzinga · Feb 26, 2026
Wells Fargo analyst Larry Biegelsen downgrades Merit Medical Systems (NASDAQ:MMSI) from Overweight to Equal-Weight and lowers the price target from $95 to $78.
Yahoo · Feb 25, 2026
MMSI beats Q4 estimates as EPS climbs 12% and margins widen, driven by strong Cardiovascular growth and solid U.S. and EMEA sales.
Benzinga · Feb 25, 2026
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and raises the price target from $106 to $109.
SeekingAlpha · Feb 25, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MMSI.
